Kedudukan dalam Saham
#27535
Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm,... Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.
Harga Saham
$0.9474
Disegerakkan terakhir: 2026-08-19
Perdagangan Lite Strategy, Inc. (LITS)
Harga LITS dengan permodalan pasaran b
Modal pasaran bagi Lite Strategy, Inc.(LITS)
Modal Pasaran: $32.24M
Sehingga August 2026, Lite Strategy, Inc. mempunyai modal pasaran sebanyak $32.24M. Ini menjadikan Lite Strategy, Inc. syarikat ke-27535th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Lite Strategy, Inc. dari 2025 hingga 2026
LITS berbanding dengan 5 teratas yang paling popular stocks
| Harga LITS |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.301T
|
+16,443,038.75%
|
|
|
|
|
$4.634T
|
+14,374,024.41%
|
|
|
|
|
$4.143T
|
+12,851,306.25%
|
|
|
|
|
$3.589T
|
+11,134,030.20%
|
|
|
|
|
$2.857T
|
+8,862,071.81%
|
